Close

Oramed Pharma (ORMP) Says FDA Meeting Provides BLA Guidance on ORMD-0801

September 5, 2017 6:21 AM EDT Send to a Friend
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced today that it has successfully concluded its meeting with the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login